Indications for adjuvant chemotherapy in patients with pT1N1M0 gastric cancer: a single-center experience.

Peng JinXiaoyan JiShuai MaWenzhe KangHao LiuYang LiFuhai MaHaitao HuWeikun LiYantao Tian

Published in: Journal of cancer research and clinical oncology (2020)

An additional survival benefit related to AC is expected for selected pT1N1M0 patients. Male patients with EN ≤ 15 may be particularly appropriate candidates for AC.

Keyphrases

end stage renal disease
ejection fraction
prognostic factors
patient reported outcomes